Assessment of Resistin Level Using Azithromycin as an Adjunctive to Non-Surgical Treatment of Periodontitis Patients with Type II Diabetes Mellitus

N. Hegab, M. Attia, O. Shaker
{"title":"Assessment of Resistin Level Using Azithromycin as an Adjunctive to Non-Surgical Treatment of Periodontitis Patients with Type II Diabetes Mellitus","authors":"N. Hegab, M. Attia, O. Shaker","doi":"10.21608/adjg.2021.48111.1316","DOIUrl":null,"url":null,"abstract":"Purpose: This study was designed to evaluate the resistin levels in gingival crevicular fluid (GCF) of patients suffering from periodontitis and type II diabetes mellitus (TIIDM) after non-surgical periodontal therapy and Azithromycin (AZM) as adjunctive therapy. Subjects and Methods: 48 patients with periodontitis their age ranging between (20-50) years old were selected for this study were divided into three groups: (group I): healthy patients with periodontitis, (group II): controlled TIIDM patients with periodontitis, and (group III): controlled TIIDM patients with periodontitis who were received AZM. All patients received non-surgical periodontal therapy (NSPT) and were examined with the following clinical periodontal parameters which are plaque index (PI), gingival index (GI), probing depth (PD) and clinical attachment level (CAL) at baseline, 1 month and 3 months. Collection of GCF samples was done in all patients at baseline, 4 weeks and 6 weeks. Following the periodontal therapy. Quantification of resistin in human samples was measured using resistin ELISA test. Results: NSPT was found to show relative improvement in all clinical parameters as well as a decline in resistin levels. In addition, GCF levels of resistin, GI and PI showed greater reduction after non-surgical treatment in group III than group I and II with nonsignificant difference. Conclusion: NSPT is found to be effective in the management of periodontitis patients with and without diabetes mellitus and also GCF resistin can be a potential biomarker to detect the periodontal disease condition. Also, adjunctive use of AZM showed clinical benefit to patients with periodontitis by its role on host response modulation. Codex : 13/22.01 azhardentj@azhar.edu.eg http://adjg.journals.ekb.eg DOI: 10.21608/adjg.2021.48111.1316 Oral Medicine & Surgical Sciences (Oral Medicine, Oral & Maxillofacial Surgery, Oral Pathology, Oral Biology)","PeriodicalId":7493,"journal":{"name":"Al-Azhar Dental Journal for Girls","volume":"12 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Al-Azhar Dental Journal for Girls","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/adjg.2021.48111.1316","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: This study was designed to evaluate the resistin levels in gingival crevicular fluid (GCF) of patients suffering from periodontitis and type II diabetes mellitus (TIIDM) after non-surgical periodontal therapy and Azithromycin (AZM) as adjunctive therapy. Subjects and Methods: 48 patients with periodontitis their age ranging between (20-50) years old were selected for this study were divided into three groups: (group I): healthy patients with periodontitis, (group II): controlled TIIDM patients with periodontitis, and (group III): controlled TIIDM patients with periodontitis who were received AZM. All patients received non-surgical periodontal therapy (NSPT) and were examined with the following clinical periodontal parameters which are plaque index (PI), gingival index (GI), probing depth (PD) and clinical attachment level (CAL) at baseline, 1 month and 3 months. Collection of GCF samples was done in all patients at baseline, 4 weeks and 6 weeks. Following the periodontal therapy. Quantification of resistin in human samples was measured using resistin ELISA test. Results: NSPT was found to show relative improvement in all clinical parameters as well as a decline in resistin levels. In addition, GCF levels of resistin, GI and PI showed greater reduction after non-surgical treatment in group III than group I and II with nonsignificant difference. Conclusion: NSPT is found to be effective in the management of periodontitis patients with and without diabetes mellitus and also GCF resistin can be a potential biomarker to detect the periodontal disease condition. Also, adjunctive use of AZM showed clinical benefit to patients with periodontitis by its role on host response modulation. Codex : 13/22.01 azhardentj@azhar.edu.eg http://adjg.journals.ekb.eg DOI: 10.21608/adjg.2021.48111.1316 Oral Medicine & Surgical Sciences (Oral Medicine, Oral & Maxillofacial Surgery, Oral Pathology, Oral Biology)
阿奇霉素辅助非手术治疗牙周炎合并2型糖尿病患者抵抗素水平的评价
目的:评价牙周炎合并2型糖尿病(TIIDM)患者在接受非手术牙周治疗和阿奇霉素(AZM)辅助治疗后龈沟液(GCF)抵抗素水平。对象与方法:选择48例年龄在(20-50)岁之间的牙周炎患者,将其分为三组:(I组)健康牙周炎患者,(II组)对照TIIDM合并牙周炎患者,(III组)对照TIIDM合并牙周炎合并AZM治疗的患者。所有患者均接受了非手术牙周治疗(NSPT),并在基线、1个月和3个月进行了以下临床牙周参数的检查:菌斑指数(PI)、牙龈指数(GI)、探诊深度(PD)和临床附着水平(CAL)。在基线、4周和6周时收集所有患者的GCF样本。牙周治疗后。采用抵抗素酶联免疫吸附试验测定人样品中抵抗素的含量。结果:NSPT在所有临床参数上均有相对改善,抵抗素水平下降。此外,抵抗素、GI、PI的GCF水平在非手术治疗后,III组比I、II组下降幅度更大,但差异无统计学意义。结论:NSPT对合并或不合并糖尿病的牙周炎患者均有较好的治疗效果,GCF抵抗素可作为牙周病病情检测的潜在生物标志物。此外,辅助使用AZM通过其对宿主反应的调节作用对牙周炎患者显示出临床益处。法典:13/22.01 azhardentj@azhar.edu.eg http://adjg.journals.ekb.eg DOI: 10.21608/adjg.2021.48111.1316口腔医学与外科科学(口腔医学,口腔颌面外科,口腔病理学,口腔生物学)
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信